Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperreactive malarial splenomegaly in pregnancy.

I Bates1

  • 1Komfo Anokye Teaching Hospital, Kumasi, Ghana.

Tropical Doctor
|July 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Building capacities in research for blood services in Africa.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2021
Same author

Conceptualising production, productivity and technology in pharmacy practice: a novel framework for policy, education and research.

Human resources for health·2018
Same author

Detection of adverse events of transfusion in a teaching hospital in Ghana.

Transfusion medicine (Oxford, England)·2017
Same author

Improving the screening of blood donors with syphilis rapid diagnostic test (RDT) and rapid plasma reagin (RPR) in low- and middle-income countries (LMIC).

Transfusion medicine (Oxford, England)·2016
Same author

Pharmacist's review and outcomes: Treatment-enhancing contributions tallied, evaluated, and documented (PROTECTED-UK).

Journal of critical care·2015
Same author

Validation of the haemoglobin colour scale for screening blood donors in Malawi.

Malawi medical journal : the journal of Medical Association of Malawi·2014

Hyperreactive malarial splenomegaly (HMS) in women of reproductive age often worsens anemia, especially during pregnancy. Management requires lifelong antimalarial treatment and supportive care to prevent severe complications.

Area of Science:

  • Tropical Medicine
  • Hematology
  • Obstetrics

Background:

  • Hyperreactive malarial splenomegaly (HMS) is prevalent in tropical regions, disproportionately affecting women of reproductive age.
  • HMS exacerbates anemia, posing significant risks to pregnant women with pre-existing nutritional deficiencies or anemia.
  • Pregnancy complicates HMS, leading to potentially life-threatening hemolytic anemia episodes, increasing fetal risks.

Purpose of the Study:

  • To highlight the challenges of managing hyperreactive malarial splenomegaly (HMS) in pregnant women.
  • To emphasize the association between HMS, anemia, and adverse pregnancy outcomes.
  • To outline current management strategies for chronic HMS.

Main Methods:

  • Literature review on hyperreactive malarial splenomegaly and pregnancy.

Related Experiment Videos

  • Analysis of clinical associations between HMS, anemia, and pregnancy outcomes.
  • Summary of established management protocols for chronic HMS.

    • Main Results:

    • HMS significantly increases the risk and severity of anemia in pregnant women.
    • Hemolytic anemia episodes during pregnancy in HMS patients pose severe maternal and fetal risks.
    • Lifelong antimalarial therapy and hematinic supplementation are standard for chronic HMS.

    Conclusions:

    • Effective management of HMS in pregnant women is crucial to mitigate severe anemia and improve maternal-fetal outcomes.
    • Prompt intervention, including blood transfusions for severe hemolysis, is vital.
    • Continuous antimalarial therapy is essential for long-term HMS control.